Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer

Anna Żaczek , Aleksandra Markiewicz , Barbara Seroczyńska , Jarosław Skokowski , Janusz Jaśkiewicz , Tadeusz Pieńkowski , Wojciech P. Olszewski , Jolanta Szade , Piotr Rhone , Marzena Wełnicka-Jaśkiewicz , Jacek Jassem

Abstract

n/a
Author Anna Żaczek (IFB / DMedB)
Anna Żaczek,,
- Department of Medical Biotechnology
, Aleksandra Markiewicz (IFB)
Aleksandra Markiewicz,,
- Intercollegiate Faculty of Biotechnology UG
, Barbara Seroczyńska
Barbara Seroczyńska,,
-
, Jarosław Skokowski
Jarosław Skokowski,,
-
, Janusz Jaśkiewicz
Janusz Jaśkiewicz,,
-
, Tadeusz Pieńkowski
Tadeusz Pieńkowski,,
-
, Wojciech P. Olszewski
Wojciech P. Olszewski,,
-
, Jolanta Szade
Jolanta Szade,,
-
, Piotr Rhone
Piotr Rhone,,
-
, Marzena Wełnicka-Jaśkiewicz
Marzena Wełnicka-Jaśkiewicz,,
-
et al.`
Journal seriesOncologist, ISSN 1083-7159, (A 35 pkt)
Issue year2012
Vol17
No10
Pages1246-1255
Keywords in Englishbreast cancer, TOP2A gene dosage, quantitative real time PCR, prognostic factor
DOIDOI:10.1634/theoncologist.2012-0023
Languageen angielski
Score (nominal)40
Publication indicators WoS Impact Factor: 2012 = 4.095 (2) - 2012=5.245 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?